☆ 4.6 Article

Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway

Dong Ma et al.

Summary: Hepatocellular carcinoma (HCC) is the third-leading cause of cancer deaths globally. Downregulation of Ficolin-3 (FCN3) protein in HCC tissues is closely related to poor prognosis. Overexpression of FCN3 induces apoptosis and inhibits cell proliferation via the p53 signaling pathway. FCN3 modulates the nuclear translocation of eukaryotic initiation factor 6 (EIF6) by binding ribosome maturation factor (SBDS) to induce ribosomal stress and activation of the p53 pathway. Y-Box Binding Protein 1 (YBX1) is involved in the transcription and translation level regulation of FCN3 to SBDS. A negative feedback loop involving p53, YBX1, and SBDS is identified downstream of FCN3.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2023)

Add to Collection

Article Cell Biology

The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest

Wenpeng Zhao et al.

Summary: AT7519, a second-generation small molecule multi-CDK inhibitor, was found to have potential for GBM treatment through high-throughput screening. It inhibits cell viability and proliferation of GBM cells, arrests the cell cycle, induces apoptosis and pyroptosis, and reduces tumor volume in animal models. AT7519 is a promising chemical for GBM treatment.

CELL DEATH & DISEASE (2023)

Add to Collection

Article Microbiology

Inhibitors of One or More Cellular Aurora Kinases Impair the Replication of Herpes Simplex Virus 1 and Other DNA and RNA Viruses with Diverse Genomes and Life Cycles

Cindy Y. Ly et al.

Summary: In this study, aurora kinase inhibitors were found to significantly reduce gene expression and viral replication of herpes simplex virus 1 (HSV-1). Furthermore, these inhibitors also showed inhibitory effects on the replication of other RNA and DNA viruses. These findings suggest a novel role for aurora kinases in the replication of diverse viruses.

MICROBIOLOGY SPECTRUM (2023)

Add to Collection

Review Surgery

Hepatocellular-Cholangiocarcinoma Collision Tumors: An Update of Current Management Practices

Brandon Goodwin et al.

Summary: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary hepatic collision tumor with a poor prognosis and lack of standardized treatment options. Surgical resection, chemotherapy, and radiation therapy are currently available treatments, but recurrence is common and survival rates are low. Further research is needed to evaluate the efficacy of systemic chemotherapy and immunotherapy in patients with unresectable disease.

AMERICAN SURGEON (2023)

Add to Collection

Article Oncology

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma

Qiangan Jing et al.

Summary: CLEC1B, encoding the CLEC-2 protein, is involved in platelet activation, angiogenesis, and immune and inflammatory responses. This study found that CLEC1B is downregulated in hepatocellular carcinoma (HCC) and has a good clinical prognostic value. CLEC1B expression is closely associated with immune cell infiltration and correlates with a variety of immunomodulators in the HCC tumor microenvironment. Furthermore, CLEC1B and its related genes or interacting proteins are implicated in multiple immune-related processes and signaling pathways. Overexpression of CLEC1B significantly influences the treatment effects of sorafenib on HCC cells.

CANCER CELL INTERNATIONAL (2023)

Add to Collection

Review Pharmacology & Pharmacy

Drug repurposing using real-world data

George S. Q. Tan et al.

Summary: The use of real-world data in drug repurposing is advantageous for supplementing de novo drug discovery and incorporating real-world evidence in regulatory approvals. A scoping review analyzed 250 studies, including hypothesis generation, hypothesis validation, and safety assessment. Challenges include isolated data sources, false-positive signals, bias and confounding in hypothesis validation, and the lack of regulatory guidance.

DRUG DISCOVERY TODAY (2023)

Add to Collection

Article Oncology

A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia

Brian A. Jonas et al.

Summary: This phase 1b clinical study evaluated the safety, efficacy, and pharmacokinetics of venetoclax in combination with alvocidib for relapsed/refractory acute myeloid leukemia (AML) patients. The combination therapy was found to be safe and tolerable, but did not significantly increase efficacy compared to single-agent treatment. Future studies could explore the role of drug sequence, dosage, and the use of a more selective MCL1 inhibitor for the relapsed/refractory AML population.

HEMATOLOGICAL ONCOLOGY (2023)

Add to Collection

Article Genetics & Heredity

Papillary Thyroid Carcinoma: A thorough Bioinformatic Analysis of Gene Expression and Clinical Data

Ivan Petrini et al.

Summary: The likelihood of being diagnosed with thyroid cancer has increased in recent years. The aim of this study is to identify potential genes relevant to Papillary Thyroid Carcinoma (PTC) through bioinformatic analysis. Four genes, PTGFR, ZMAT3, GABRB2, and DPP6, were found to be highly relevant and worthy of further investigation.

GENES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

A Rodent Model of Human-Dose-Equivalent 5-Fluorouracil: Toxicity in the Liver, Kidneys, and Lungs

Mariana Conceicao da Silva et al.

Summary: This study examined the effects of 5-FU clinical treatment on the liver, kidneys, and lungs of rats, and found different levels of toxicity, including oxidative stress and inflammation, in these organs. These results will contribute to the search for new adjuvant therapies to attenuate the adverse effects of 5-FU.

ANTIOXIDANTS (2023)

Add to Collection

Article Medicine, Research & Experimental

Widespread genomic/molecular alterations of DNA helicases and their clinical/therapeutic implications across human cancer

Xin Qin et al.

Summary: DNA helicases play a crucial role in maintaining genomic stability, and mutations in these genes can lead to genomic instability and cancer susceptibility. Interestingly, overexpression of DNA helicases is observed in certain cancers. In this study, genomic and molecular alterations in 12 important DNA helicases were analyzed across various types of cancers. The study revealed significant expression heterogeneity among these helicases, and tumors were classified into subtypes based on their DNA helicase score. The high DNA helicase score subtypes were associated with stemness, proliferation, oncogenic signaling, longer telomeres, more mutations, copy number alterations, and shorter survival. Furthermore, high DNA helicase scores were linked to sensitivity to chemo- and radio-therapies, as well as defects in DNA repair pathways like homologous recombination deficiency. Importantly, a potential DNA helicase inhibitor, Danusertib, was identified in this study. These findings highlight the dysregulation of DNA helicases in cancer and their potential as therapeutic targets.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Review Chemistry, Medicinal

Bioinformatics Paradigms in Drug Discovery and Drug Development

Ravinder Sharma et al.

Summary: Despite challenges in drug development, bioinformatics analysis using integrated genomics, proteomics, and bioinformatics can accelerate drug discovery and characterization while also predicting adverse effects and drug resistance. Combinatorial techniques such as proteomics, genomics, bioinformatics, molecular docking, and mass spectrometry have been crucial in understanding the drug-creation process. This article provides an overview of these techniques and their importance in drug development.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2023)

Add to Collection

Article Environmental Sciences

Cadmium modulates steatosis, fibrosis, and oncogenic signaling in liver cancer cells by activating notch and AKT/mTOR pathways

Suryakant Niture et al.

Summary: This study investigated the effects of low concentrations of cadmium (Cd) on liver cancer cell proliferation, steatosis, and fibrogenic/oncogenic signaling. Cd exposure increased reactive oxygen species production, enhanced cell proliferation, and activated Notch and AKT/mTOR pathways in liver cancer cells. Cd also induced cell steatosis and fibrogenic signaling. These findings suggest that low concentrations of Cd modulate steatosis, fibrogenic, and oncogenic signaling in liver cancer cells.

ENVIRONMENTAL TOXICOLOGY (2023)

Add to Collection

Review Pharmacology & Pharmacy

Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)

Vasileios-Periklis Stamatellos et al.

Summary: This article reviews the available safety data for Disease-Modifying Therapies (DMTs) for Multiple Sclerosis and presents the monitoring plan before and during treatment.

CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY (2023)

Add to Collection

Article Medicine, Research & Experimental

Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519

Kaja Karas et al.

Summary: This study found that AT7519 inhibits proliferation, migration, and clonogenicity of hepatocellular carcinoma (HCC) cells, and affects a substantial portion of genes associated with HCC development and progression. Additionally, the combination of AT7519 with gefitinib or cabozantinib enhances the sensitivity of HCC cells to these drugs. Therefore, AT7519 shows potential for monotherapy or combination therapy with gefitinib or cabozantinib in HCC treatment.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/ HuR pathway

Jing-Ting Chiou et al.

Summary: Accumulating evidence suggests that the anticancer activity of acridine derivatives in leukemia cells is achieved by regulating the expression of BCL2 family proteins, including BCL2L1. Amsacrine inhibits the expression of BCL2L1 in K562 cells, leading to apoptosis. This downregulation is mediated by the SIDT2/NOX4/ERK pathway, which results in the downregulation of HuR and subsequent degradation of BCL2L1 mRNA. This pathway is also observed in other leukemia cell lines.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway

Dong Ma et al.

Summary: Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths worldwide, and current treatment strategies have limited effectiveness. This study identified Ficolin-3 (FCN3) as a potential prognostic factor for HCC, with decreased expression associated with poor prognosis. Overexpression of FCN3 was found to induce apoptosis and inhibit cell proliferation through the p53 signaling pathway. Furthermore, FCN3 was shown to modulate nuclear translocation of EIF6 by binding to SBDS, leading to ribosomal stress and activation of the p53 pathway. Y-Box Binding Protein 1 (YBX1) was also found to regulate FCN3 and SBDS at the transcription and translation level. Additionally, a negative feedback loop involving p53, YBX1, and SBDS was identified downstream of FCN3.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2023)

Add to Collection

Article Endocrinology & Metabolism

Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma

Zijian Yang et al.

Summary: Elevated lactate levels in hepatocellular carcinoma cells lead to increased lactylation modification of core histones. Lactylation affects biological processes in tumor cells, particularly enzymes involved in metabolic pathways.

NATURE METABOLISM (2023)

Add to Collection

Review Oncology

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma

Xiufeng Zheng et al.

Summary: GPC3 is specifically up-regulated in hepatocellular carcinoma and has shown promising value in diagnosis and treatment. GPC3-based therapeutic methods such as vaccines, immunotoxins, and CAR T or NK cells have emerged with exciting results.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

AT7519 against lung cancer via the IL6/STAT3 signaling pathway

Feng Zhou et al.

Summary: AT7519, a CDK inhibitor, exhibits great anti-tumor effects in lung cancer by blocking IL-6/STAT3 pathway and inhibiting cell proliferation and inducing apoptosis.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Add to Collection

Review Oncology

Hepcidin in hepatocellular carcinoma

Jonathan H. Joachim et al.

Summary: This review explores the regulation and action of hepcidin in hepatocellular carcinoma (HCC). It discusses the levels of tissue and serum hepcidin, the mechanisms contributing to hepcidin reduction, and the role of hepcidin in the diagnosis, prognosis, and therapeutics of HCC.

BRITISH JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma

Weiqiang Fan et al.

Summary: This study found that FOXM1 and PLK1 were overexpressed in HCC tumor tissues, and their coordinated overexpression was associated with poor prognosis of patients with HCC.

ONCOLOGY LETTERS (2022)

Add to Collection

Article Immunology

A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma

Xing Lai et al.

Summary: This study identified three critical survival-related genes for hepatocellular carcinoma (HCC) patients and developed a prognostic prediction model using CDC20 and FCN3. The study also observed a positive correlation between risk score and immune infiltration abundance in HCC.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/beta-catenin signaling pathway

Hui Xu et al.

Summary: In this study, the researchers investigated the role of miR-582-3p in hepatocellular carcinoma (HCC) and found that its upregulation inhibited the proliferation and migration of HCC cells and suppressed tumor growth. They also discovered that miR-582-3p regulates the Wnt/β-catenin signaling pathway by targeting RRM2, thereby blocking the progression of HCC.

BIOENGINEERED (2022)

Add to Collection

Article Genetics & Heredity

Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments

Xueting Hu et al.

Summary: By bioinformatics analysis, this study identified critical pathways and hub genes in hepatocellular carcinoma (HCC), and found that the RRM2 inhibitor osalmid exhibited anti-tumor activity.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Genetics & Heredity

A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening

Min Chen et al.

Summary: This study established a diagnostic model based on an artificial neural network using gene expression data of hepatocellular carcinoma (HCC), and identified diagnostic-related genes and potential drugs for HCC therapy.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Biochemical Research Methods

GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels

Chun-Jie Liu et al.

Summary: In this study, GSCALite was upgraded to GSCA, a gene set-based cancer analysis platform that integrates multi-omics data from four public sources and provides functionalities for exploring, analyzing, and visualizing gene expression, genomic variations, tumor immune infiltration, drug sensitivity, and their associations with clinical outcomes. Case studies proved the advantage of GSCA over single gene analysis in discovering novel associations between gene set expression/mutation and clinical outcomes in different cancer types.

BRIEFINGS IN BIOINFORMATICS (2022)

Add to Collection

Article Medicine, General & Internal

Identification of Novel Genes and Associated Drugs in Advanced Clear Cell Renal Cell Carcinoma by Bioinformatic Methods

Meiqi Lu et al.

Summary: This study identified potential biomarkers and drugs for advanced clear cell renal cell carcinoma (ccRCC) by screening differentially expressed genes (DEGs). Survival analysis showed that certain genes might participate in cancer occurrence, migration, and relapse of ccRCC. Gene-drug analysis identified drugs strongly associated with specific genes, which could be used for treating advanced ccRCC.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Add to Collection

Article Biochemical Research Methods

Network analysis of TCGA and GTEx gene expression datasets for identification of trait-associated biomarkers in human cancer

Huey-Miin Chen et al.

Summary: Advancements in high-throughput sequencing technologies have enabled the generation of extensive volumes of OMICs data, allowing for systematic data analysis and the discovery of novel biological insights. This study presents protocols for analyzing differentially expressed genes in TCGA and GTEx RNA-Seq data from human cancers, conducting comprehensive integrative GO and network analyses with a focus on clinical and survival data, as well as identifying differential correlations of trait-associated biomarkers.

STAR PROTOCOLS (2022)

Add to Collection

Article Cell Biology

Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma

You-Liang Lai et al.

Summary: DBPR114 showed activity against HCC tumor cell proliferation in vitro regardless of p53 alteration status and tumor grade. It induced growth inhibition in HCC cells through apoptosis induction, cell cycle arrest, and polyploidy formation. DBPR114 also exhibited anti-angiogenic effects and significantly inhibited tumor growth in multiple HCC tumor xenograft models.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Add to Collection

Article Chemistry, Medicinal

A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent

Jing Ma et al.

Summary: A novel polyamine conjugate 13b demonstrated significantly elevated anti-tumor and anti-metastatic effects in vivo compared to a positive control, possibly through targeting multiple molecular mechanisms for inhibiting HCC metastasis, suggesting a promising strategy for treating HCC with reduced toxicities and notable activities.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Biochemical Research Methods

OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features

Billy Zeng et al.

Summary: Precision medicine is allowing for tailored treatments for cancer patients based on their molecular and clinical features. By matching cancer-specific gene expression signatures to compound-induced profiles, researchers can efficiently identify potential drug candidates that reverse the expression of disease-related genes.

NATURE PROTOCOLS (2021)

Add to Collection

Article

Early-Life Exposure to Low-Dose Cadmium Accelerates Diethylnitrosamine and Diet-Induced Liver Cancer

Hongbo Men et al.

Oxidative Medicine and Cellular Longevity (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Comprehensive Analysis of Gene Expression Changes and Validation in Hepatocellular Carcinoma

Hao Zhang et al.

Summary: This study aimed to analyze the involvement of hub genes in hepatocellular carcinoma. Through analyzing 107 differentially expressed genes, it was found that CCNB1, CDK1, CDC20, PTTG1, CCNA2, and TTK were overexpressed and correlated in hepatocellular carcinoma cells and tumors, particularly in the cell cycle pathway. The results may contribute to exploring the prognosis and diagnostic markers of HCC.

ONCOTARGETS AND THERAPY (2021)

Add to Collection

Article Oncology

Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer

Robson Francisco Carvalho et al.

Summary: Rectal cancer is a significant global health issue, with varying responses to neoadjuvant therapy. Drug repositioning, particularly with approved topoisomerase II inhibitors, shows promise in treating rectal cancer. Genetic analysis and drug screenings have identified potential targeted therapies based on topoisomerase II inhibitor efficacy, offering personalized treatment options for rectal cancer patients.

CANCERS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Podophyllotoxin: History, Recent Advances and Future Prospects

Zinnia Shah et al.

Summary: Podophyllotoxin and its congeners are recognized as broad-spectrum pharmacologically active compounds, but face challenges such as low bioavailability, systemic toxicity, and drug resistance, while the production of synthetic derivatives is not economically feasible. Continuous efforts to improve drug availability and seek structure optimization strategies are necessary.

BIOMOLECULES (2021)

Add to Collection

Article Cell Biology

Selected using bioinformatics and molecular docking analyses, PHA-793887 is effective against osteosarcoma

Bo Wu et al.

Summary: Novel prognostic and therapeutic targets for osteosarcoma patients were identified through gene expression analysis, with CDK1 and topoisomerase II alpha mRNA levels found to correlate with patient prognosis. Computational techniques were used to screen for potential CDK1 inhibitor PHA-793887, which was shown to be effective in reducing viability and clonogenicity of osteosarcoma cells in vitro.

AGING-US (2021)

Add to Collection

Article Oncology

Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress

Zetian Shen et al.

Summary: This study evaluated the anti-tumor effect of co-inhibition of AURKA and HSF1 on hepatocellular carcinoma (HCC) cells, both in vitro and in vivo. The results showed that the combined inhibition led to increased cell apoptosis, potentially mediated by the endoplasmic reticulum stress (ERS) pathway. These findings suggest that AURKA and HSF1 may be promising targets for HCC treatment.

CELLULAR ONCOLOGY (2021)

Add to Collection

Article Oncology

Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis

Sumei Wang et al.

Summary: This study identified candidate hub genes associated with overall survival in HCC patients through gene expression and network analysis. These findings contribute new insights for the precise diagnosis, clinical treatment, and prognosis of HCC in the future.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma

Qiuxian Zheng et al.

Summary: Recent studies have shown that the transcription factor E2F4 is involved in tumor progression, with elevated expression in HCC tumor tissue compared to normal tissue. Overexpression of E2F4 is associated with poor prognosis in HCC patients, and is positively correlated with immune cell infiltration. E2F4 may serve as a novel biomarker for HCC diagnosis and prognosis prediction.

JOURNAL OF CANCER (2021)

Add to Collection

Article Medicine, Research & Experimental

CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling

Jianqing Yu et al.

Summary: The study revealed that CYP1A2 is significantly down-regulated in HCC tumor tissues and its high expression is associated with better prognosis. CYP1A2 functions as a tumor suppressor in HCC by inhibiting HGF/MET signaling and MMPs expression, thus reducing cell growth and invasion capabilities.

THERANOSTICS (2021)

Add to Collection

Article Cell Biology

Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis

Yuanyuan Wang et al.

Summary: The study identified key genes and their potential mechanisms in LUAD through bioinformatics analysis, revealing 22 core genes significantly associated with reduced survival rates, and five key genes involved in the cell cycle pathway in LUAD. The relationship between these key genes and certain drugs may provide clues for the treatment and prognosis of LUAD.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Add to Collection

Article Hematology

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease

Gaurav Goyal et al.

HAEMATOLOGICA (2020)

Add to Collection

Review Pharmacology & Pharmacy

Bioinformatics Approaches for Anti-cancer Drug Discovery

Kening Li et al.

CURRENT DRUG TARGETS (2020)

Add to Collection

Review Oncology

The role of cladribine in acute myeloid leukemia: an old drug up to new tricks

Matteo Molica et al.

LEUKEMIA & LYMPHOMA (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Covalent Aurora A regulation by the metabolic integrator coenzyme A

Yugo Tsuchiya et al.

REDOX BIOLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Early Diagnosis of Hepatocellular Carcinoma Using Machine Learning Method

Zi-Mei Zhang et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

New advances in the diagnosis and management of hepatocellular carcinoma

Ju Dong Yang et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Editorial Material Oncology

Doxorubicin for the treatment of hepatocellular carcinoma: GAME OVER!

Boris Guiu et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Mathematical & Computational Biology

CancerLivER: a database of liver cancer gene expression resources and biomarkers

Harpreet Kaur et al.

DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2020)

Add to Collection

Article Medicine, General & Internal

Identification of key genes and pathways in hepatocellular carcinoma A preliminary bioinformatics analysis

Min Wu et al.

MEDICINE (2019)

Add to Collection

Review Pharmacology & Pharmacy

DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report

Theodore J. Wigle et al.

PHARMACEUTICS (2019)

Add to Collection

Article Gastroenterology & Hepatology

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma

Ya-Bin Wang et al.

GASTROENTEROLOGY REPORT (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial

Boris Guiu et al.

RADIOLOGY (2019)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Is Idarubicin the Future of TACE?

Siddharth A. Padia

RADIOLOGY (2019)

Add to Collection

Review Neurosciences

Local Drug Delivery for Prevention of Hearing Loss

Leonard P. Rybak et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Systemic doxorubicin and hepatocellular carcinoma: the end of an era never risen up

John E. Eaton et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis

Wan-Xia Yang et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Add to Collection

Article Cell & Tissue Engineering

Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis

Zengyuan Zhou et al.

CELL TRANSPLANTATION (2019)

Add to Collection

Article Biochemistry & Molecular Biology

TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions

Heonjong Han et al.

NUCLEIC ACIDS RESEARCH (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Protective effects of kenpaullone on cardiomyocytes following H2O2-induced oxidative stress are attributed to inhibition of connexin 43 degradation by SGSM3

Hyun-Chel Joo et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Add to Collection

Article Biochemical Research Methods

GSCALite: a web server for gene set cancer analysis

Chun-Jie Liu et al.

BIOINFORMATICS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks

Daniel J. B. Clarke et al.

NUCLEIC ACIDS RESEARCH (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients

Liping Zhuang et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma

Xueren Gao et al.

BIOSCIENCE REPORTS (2018)

Add to Collection

Article Oncology

Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis

Lin Li et al.

ONCOLOGY REPORTS (2017)

Add to Collection

Article Multidisciplinary Sciences

Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets

Bin Chen et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Multidisciplinary Sciences

Comprehensive analysis of normal adjacent to tumor transcriptomes

Dvir Aran et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Review Chemistry, Multidisciplinary

Recent Advances in the Chemistry and Biology of Podophyllotoxins

Xiang Yu et al.

CHEMISTRY-A EUROPEAN JOURNAL (2017)

Add to Collection

Article Biochemistry & Molecular Biology

DGIdb 2.0: mining clinically relevant drug-gene interactions

Alex H. Wagner et al.

NUCLEIC ACIDS RESEARCH (2016)

Add to Collection

Article Pharmacology & Pharmacy

Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II

Ka C. Lee et al.

BIOCHEMICAL PHARMACOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Maxim V. Kuleshov et al.

NUCLEIC ACIDS RESEARCH (2016)

Add to Collection

Article Biology

CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks

Yu Tang et al.

BIOSYSTEMS (2015)

Add to Collection

Article Biochemical Research Methods

InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams

Henry Heberle et al.

BMC BIOINFORMATICS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Add to Collection

Article Biology

Selecting biologically informative genes in co-expression networks with a centrality score

Francisco J. Azuaje

BIOLOGY DIRECT (2014)

Add to Collection

Review Biochemistry & Molecular Biology

From protein interaction networks to novel therapeutic strategies

Samira Jaeger et al.

IUBMB LIFE (2012)

Add to Collection

Article Biochemical Research Methods

Use of Kinase Inhibitors to Correct ΔF508-CFTR Function

Agata M. Trzcinska-Daneluti et al.

MOLECULAR & CELLULAR PROTEOMICS (2012)

Add to Collection

Article Biochemical Research Methods

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Mark D. Robinson et al.

BIOINFORMATICS (2010)

Add to Collection

Article Oncology

AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples

Matthew S. Squires et al.

MOLECULAR CANCER THERAPEUTICS (2010)

Add to Collection

Article Biochemistry & Molecular Biology

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition

L. Santo et al.

ONCOGENE (2010)

Add to Collection

Article Biochemical Research Methods

Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt

Steffen Durinck et al.

NATURE PROTOCOLS (2009)

Add to Collection

Article Oncology

Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model

Daniel Benten et al.

NEOPLASIA (2009)

Add to Collection

Article Pharmacology & Pharmacy

The role of CDK5/P25 formation/inhibition in neurodegeneration

Antoni Camins et al.

DRUG NEWS & PERSPECTIVES (2006)

Add to Collection

Review Oncology

5-Fluorouracil: Mechanisms of action and clinical strategies

DB Longley et al.

NATURE REVIEWS CANCER (2003)

Add to Collection

Article Biochemistry & Molecular Biology

Cytoscape: A software environment for integrated models of biomolecular interaction networks

P Shannon et al.

GENOME RESEARCH (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.